March 1: The FDA on Friday granted full approval of J&Js Rybrevant in combination with chemotherapy as a first-line treatment for patients with non-small cell lung cancer (NSCLC) EGFR exon 20 insertion mutations, the company announced
Cost planning: Our peptide cost calculator helps you budget for long-term use without surprises
If your blood sugar levels are always high, they may suggest slowly increasing your dose
Metabolic Syndrome Patients with insulin resistance, elevated blood sugar, high triglycerides, or other metabolic markers who need both weight loss and metabolic improvement
The Alliance for Pharmacy Compounding, which says that millions of doses of semaglutide and tirzepatide have been prepared and dispensed by compounding pharmacies across the US over the last two years, questioned whether the FDA had considered the number of patients who would need to transition from compounded semaglutide to the FDA-approved brands before changing its status.
We offer flexible options to make your treatment accessible: We provide telehealth services across the entire state, including: Atlanta, Savannah, Augusta, Columbus, Macon, Athens, Roswell, Albany, Marietta, Warner Robins, Valdosta, Smyrna, Dunwoody, Gainesville, Peachtree City, and more
